A tetramer assay showed that the number of AH-1+ CD8+ T cells was significantly increased in tumor-bearing mice compared with naïve mice (Fig. 2A), indicating that the presence of CT26 tumor cells primes and increases the tumor-specific lymphocytes. This evidence concerns the gene CD8A and neoplasm.